Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

MYLAN

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 40
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 42
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

TEVA

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 40
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

HALEON US HOLDINGS

  • FDA Approval
  • Sept. 10, 2024, 18:13 UTC
  • 46
  • 0 comments

FDA approve DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN

Comment Full text

HETERO LABS LTD

  • FDA Approval
  • Sept. 10, 2024, 15:56 UTC
  • 39
  • 0 comments

FDA approve LINAGLIPTIN

Comment Full text

ALVOGEN

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 44
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE

Comment Full text

WELDING

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 37
  • 0 comments

FDA approve CABERGOLINE

Comment Full text

HOSPIRA

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 42
  • 0 comments

FDA approve VERAPAMIL HYDROCHLORIDE

Comment Full text

MCPRF

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 42
  • 0 comments

FDA approve CHOLINE C-11

Comment Full text

ACTAVIS TOTOWA

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 34
  • 0 comments

FDA approve DESIPRAMINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 313
  • 314
  • 315
  • 316
  • 317
  • Next

Search

News categories

  • Technical Exchange News(10613)
  • Event(2032)
  • SEC News(185160)
  • FDA Approval(9858)
  • Company Report(721)
  • Business News(122567)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin